Thermo Fisher Scientific GIBCO CTS LV-MAX Lentiviral Production System

Monday, 13 May, 2019 | Supplied by: Thermo Fisher Scientific


The GIBCO CTS LV-MAX Lentiviral Production System, from Thermo Fisher Scientific, is a complete lentivirus production solution designed to produce high-titre lentiviral vectors greater than 1 x 108 TU/mL (unconcentrated). It is an optimised LV vector production system in suspension culture designed to meet USP <1043> standards.

The system provides a smooth transition from discovery through clinical and commercial manufacturing. It is designed to reduce the cost of viral production, simplify researchers’ workflow, utilise regulatory compliant reagents and provide a clear path towards commercialisation. The cGMP-banked HEK293 cell line for LV production facilitates large-scale production.

Online: thermofisher.com
Phone: 1300 735 292
Related Products

Bioss In Vivo Biosimilar Antibodies

Bioss In Vivo Biosimilar Antibodies are research-grade copies of therapeutic antibodies that are...

LSBio virology research products

LSBio offers antibodies, proteins, ELISA kits, assay kits and chemical compounds used by...

Beckman Coulter Life Sciences IR820 and IR870 infrared dye antibody conjugates

The products provide research flow cytometry labs with a low-noise solution, including single...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd